SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 14, 2019. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves to announce the issuance of a November 2019 Shareholder Letter.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a shareholder communication rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the body of this Form 8-K. The sole event reported is the distribution of the Shareholder Letter referenced in Exhibit 99.1.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, and contingencies are contained within the attached Shareholder Letter (Exhibit 99.1) and are not summarized in the text of this Form 8-K. The filing does not disclose unusual items.
Investor Verification Checklist
- Verify the content of the November 2019 Shareholder Letter filed as Exhibit 99.1 for actual financial updates and strategic outlook.
- Confirm the company name is BioSig Technologies, Inc. (BSGM), as the input metadata incorrectly referenced "Streamex Corp."
- Review the press release dated November 14, 2019, for any immediate market-moving announcements.